<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta><journal-id journal-id-type="nlm-ta">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosntds</journal-id><issn pub-type="epub">1935-2735</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="publisher-id">PNTD-D-11-00534</article-id><article-id pub-id-type="doi">10.1371/journal.pntd.0001738</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Viewpoints</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Medicine</subject>
          <subj-group>
            <subject>Epidemiology</subject>
          </subj-group>
          <subj-group>
            <subject>Global health</subject>
          </subj-group>
          <subj-group>
            <subject>Infectious diseases</subject>
          </subj-group>
          <subj-group>
            <subject>Pediatrics</subject>
          </subj-group>
          <subj-group>
            <subject>Public health</subject>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Public Health and Epidemiology</subject>
          <subject>Infectious Diseases</subject>
          <subject>Pediatrics and Child Health</subject>
        </subj-group>
      </article-categories><title-group><article-title>Integration of Deworming into HIV Care and Treatment: A Neglected Opportunity</article-title></title-group><contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Gerns</surname>
            <given-names>Helen L.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Sangaré</surname>
            <given-names>Laura R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Walson</surname>
            <given-names>Judd L.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
      </contrib-group><aff id="aff1">
        <label>1</label>
        <addr-line>Department of Epidemiology, University of Washington, Seattle, Washington, United States of America</addr-line>
      </aff><aff id="aff2">
        <label>2</label>
        <addr-line>Department of Global Health, University of Washington, Seattle, Washington, United States of America</addr-line>
      </aff><aff id="aff3">
        <label>3</label>
        <addr-line>Department of Medicine, University of Washington, Seattle, Washington, United States of America</addr-line>
      </aff><contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Brooker</surname>
            <given-names>Simon</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group><aff id="edit1">
        <addr-line>London School of Hygiene &amp; Tropical Medicine, United Kingdom</addr-line>
      </aff><author-notes>
        <corresp id="cor1">* E-mail: <email xlink:type="simple">hgerns@uw.edu</email></corresp>
        <fn fn-type="conflict">
          <p>The authors have declared that no competing interests exist.</p>
        </fn>
      </author-notes><pub-date pub-type="collection">
        <month>7</month>
        <year>2012</year>
      </pub-date><pub-date pub-type="epub">
        <day>31</day>
        <month>7</month>
        <year>2012</year>
      </pub-date><volume>6</volume><issue>7</issue><elocation-id>e1738</elocation-id><permissions>
        
        <copyright-holder>Gerns et al</copyright-holder>
        <license xlink:type="simple">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions><funding-group>
        <funding-statement>This publication was made possible by Grant Number TL1 RR 025016 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and by the University of Washington Center for AIDS Research, Scientific Program on HIV and co-infections. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. The funders had no role in preparation of this manuscript.</funding-statement>
      </funding-group><counts>
        <page-count count="2"/>
      </counts></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title/>
      <p>In sub-Saharan Africa, where two-thirds of all HIV-infected individuals reside, many are now aware of their HIV infection status and millions are receiving antiretroviral therapy. In many countries in the region, new infections are declining and individuals are living longer with treatment to control their HIV infection. The infrastructure behind HIV care and treatment is vital in addressing the HIV pandemic, and similarly could be utilized to address and promote other health issues specific to persons living with HIV.</p>
      <p>An estimated 2.1 million children are infected with HIV in sub-Saharan Africa, where multiple helminth species are also endemic <xref ref-type="bibr" rid="pntd.0001738-UNAIDS1">[1]</xref>. Likely half of these children are co-infected with helminths <xref ref-type="bibr" rid="pntd.0001738-Brooker1">[2]</xref>. The most recognized consequences of helminth infection in children include anemia, malnutrition, and impaired cognitive development, which are independent risk factors for death among HIV-infected children. Standard treatment of soil-transmitted helminth infection entails a single 400 mg dose of albendazole <xref ref-type="bibr" rid="pntd.0001738-Bethony1">[3]</xref>, making routine deworming of children a simple intervention that safely and affordably prevents the adverse effects of chronic helminth infection. Deworming HIV-infected children, specifically, may have a substantial impact on child health through the synergistic effects of improved nutritional status, greater control of other infectious diseases, and increased vaccine responsiveness, and therefore should be provided though HIV care services <xref ref-type="bibr" rid="pntd.0001738-Bethony1">[3]</xref>.</p>
      <p>Helminth infection in HIV-infected children may impact how the host responds to infectious diseases and immunizations, indirectly through the pathway of malnutrition, as well as directly through immunologic mechanisms. Beyond nutritional deficits, helminths also induce immunosuppressive responses, creating an ideal environment for chronic helminth infection, and inhibiting the host's ability to control other diseases such as HIV <xref ref-type="bibr" rid="pntd.0001738-Moreau1">[4]</xref>, <xref ref-type="bibr" rid="pntd.0001738-Blish1">[5]</xref>. Clinical studies suggest that deworming HIV-infected individuals may delay HIV progression, as measured by CD4 count and HIV viral load <xref ref-type="bibr" rid="pntd.0001738-Sangare1">[6]</xref>–<xref ref-type="bibr" rid="pntd.0001738-Walson3">[9]</xref>. It is plausible that in addition to improving nutritional status, eliminating helminths in infected individuals may directly impact control of other infectious diseases such as HIV.</p>
      <p>Helminth infection may also undermine the benefits of childhood immunizations, through malnutrition, and also by diminishing immune responses to vaccines, both at the time of vaccination and at disease exposure. Population-level data show that regional variations in vaccine efficacy correlate with variations in the prevalence of enteric pathogens <xref ref-type="bibr" rid="pntd.0001738-Levine1">[10]</xref>. For example, rotavirus vaccine efficacy may be 50% higher in developed countries compared to Africa and Asia <xref ref-type="bibr" rid="pntd.0001738-Walker1">[11]</xref>. Polio eradication efforts have also been challenged by diminished efficacy of the oral polio vaccine in India as compared to the rest of the world <xref ref-type="bibr" rid="pntd.0001738-Grassly1">[12]</xref>. While the distribution of soil-transmitted helminths represents only one of several factors contributing to these regional variations in vaccine responsiveness, it is a factor which can be easily targeted and controlled through routine deworming <xref ref-type="bibr" rid="pntd.0001738-Labeaud1">[13]</xref>.</p>
      <p>Individual-level evidence also suggests that helminth infection impacts immunologic responses to vaccines. Experimental human and animal studies have shown deworming before immunization increases protective antibody titers, while decreasing immuno-regulatory cytokines <xref ref-type="bibr" rid="pntd.0001738-Elias1">[14]</xref>–<xref ref-type="bibr" rid="pntd.0001738-Dadara1">[16]</xref>. Children who failed to respond to oral poliovirus vaccination were 25% (<italic>p</italic> = 0.04) more likely to harbor infections with intestinal parasites than vaccine responders <xref ref-type="bibr" rid="pntd.0001738-Triki1">[17]</xref>. Additionally, children with ascariasis who received albendazole prior to receiving oral cholera vaccine were 88% (<italic>p</italic> = 0.06) more likely to seroconvert than children who were not dewormed <xref ref-type="bibr" rid="pntd.0001738-Cooper1">[18]</xref>. Interactions that diminish responses to vaccines at the time of vaccination may also diminish immune recall of vaccines at the time of disease exposure. As HIV-infected children are more susceptible to vaccine preventable illness and death than other children <xref ref-type="bibr" rid="pntd.0001738-Roca1">[19]</xref>, even after the introduction of anti-retroviral therapy <xref ref-type="bibr" rid="pntd.0001738-Bekker1">[20]</xref>, deworming HIV-infected children may have a measurable impact on vaccine preventable infections.</p>
      <p>The World Health Organization (WHO) recommends annual or bi-annual school-based deworming as a cost-effective strategy to diminish the consequences of chronic helminth infection. Deworming could also be considered part of the nutritional care package for HIV-infected children, to reduce the consequences of malnutrition and anemia in HIV. Incorporating deworming into routine HIV care and treatment is an ideal way to improve the nutritional health of HIV-infected children, and may provide additional benefits. This may be particularly beneficial for children under 5 years of age, who represent 10%–20% of the 2 billion people infected with helminths worldwide <xref ref-type="bibr" rid="pntd.0001738-Albonico1">[21]</xref>. Annual deworming of preschool-age children is safe and highly effective in reducing parasite prevalence and intensity, malnutrition, and risk of stunting, but a formal policy does not yet exist to target this age group <xref ref-type="bibr" rid="pntd.0001738-Albonico1">[21]</xref>, <xref ref-type="bibr" rid="pntd.0001738-WHO1">[22]</xref>. Because children are infected and often diagnosed with HIV while very young, preschool-aged children can easily be dewormed in HIV clinics, along with siblings, to reduce the occurrence of reinfection.</p>
      <p>Despite WHO recommendations, school-based implementation is not universal and many helminth-infected school-age children go untreated. Children who are sick or otherwise unable to attend school may miss school-based interventions, leading to more illness and absenteeism. Children with HIV may also be less likely to receive other health services. For example, HIV-infected children are less likely to receive complete vaccination series compared to uninfected children <xref ref-type="bibr" rid="pntd.0001738-Ndirangu1">[23]</xref>. HIV care centers are an important, and highly accessed, point of serial contact for HIV-infected children and their families <xref ref-type="bibr" rid="pntd.0001738-DeBaets1">[24]</xref>. However, at present they often provide a narrow range of services. In addition to integrating deworming into current HIV treatment, the integration of other necessary childhood health interventions, including vitamin supplementation, immunizations, safe drinking water (through home water filtration), and insecticide-treated bed nets, may further reduce HIV-related morbidity and mortality among these children <xref ref-type="bibr" rid="pntd.0001738-DeBaets1">[24]</xref>.</p>
      <p>Challenges may exist in coupling other health interventions to HIV care, but the potential benefits warrant consideration. Deworming both in schools and HIV clinics is likely justified by the high rates of recurrent infection in children and the low cost of the intervention. Finally, little evidence exists on the impact of deworming in HIV-infected children, highlighting a need for more rigorous studies. These studies should investigate the effects of helminth infection on responses to immunizations, the potential interactions between antihelminthics and HIV treatment, the optimal timing of deworming around both immunizations and ART initiation, and the impact of deworming on incidence of vaccine preventable infections.</p>
      <p>The benefits of treating and preventing helminth infections in HIV-infected children may go beyond the improved nutritional status and cognitive development observed in all children to also include improved responses to immunizations and control of other infectious diseases. Enhanced control of neglected infectious diseases, such as helminth infections, through existing HIV care and treatment programs, may further reduce childhood morbidity and mortality in this vulnerable population.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>Dr. Noel S. Weiss is thanked for his editorial comments on this manuscript.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="pntd.0001738-UNAIDS1">
        <label>1</label>
        <mixed-citation publication-type="other" xlink:type="simple">UNAIDS (2008) HIV and AIDS estimates and data, 2007 and 2001. 2008 Report on the global AIDS epidemic. Geneva: UNAIDS.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Brooker1">
        <label>2</label>
        <mixed-citation publication-type="book" xlink:type="simple">Brooker S, Clements ACA, Bundy DAP (2006) Global epidemiology, ecology and control of soil-transmitted helminth infections. In: Advances in parasitology. Simon I, Hay AG, David JR, editors. Academic Press. 221–261.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Bethony1">
        <label>3</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bethony</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Brooker</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Albonico</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Geiger</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Loukas</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm</article-title>. <source>Lancet</source> <volume>367</volume>: <fpage>1521</fpage>–<lpage>1532</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Moreau1">
        <label>4</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moreau</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Chauvin</surname><given-names>A</given-names></name> (<year>2010</year>) <article-title>Immunity against helminths: interactions with the host and the intercurrent infections</article-title>. <source>J Biomed Biotechnol</source> <volume>2010</volume>: <fpage>428593</fpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Blish1">
        <label>5</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Blish</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Sangare</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Herrin</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Richardson</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>John-Stewart</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Changes in plasma cytokines after treatment of ascaris lumbricoides infection in individuals with HIV-1 infection</article-title>. <source>J Infect Dis</source> <volume>201</volume>: <fpage>1816</fpage>–<lpage>1821</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Sangare1">
        <label>6</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sangare</surname><given-names>LR</given-names></name>, <name name-style="western"><surname>Herrin</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>John-Stewart</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Walson</surname><given-names>JL</given-names></name> (<year>2011</year>) <article-title>Species-specific treatment effects of helminth/HIV-1 co-infection: a systematic review and meta-analysis</article-title>. <source>Parasitology</source> <volume>138</volume>: <fpage>1546</fpage>–<lpage>1558</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Walson1">
        <label>7</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Walson</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Herrin</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>John-Stewart</surname><given-names>G</given-names></name> (<year>2009</year>) <article-title>Deworming helminth co-infected individuals for delaying HIV disease progression</article-title>. <source>Cochrane Database Syst Rev</source> <fpage>CD006419</fpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Walson2">
        <label>8</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Walson</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Otieno</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Mbuchi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Richardson</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Lohman-Payne</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial</article-title>. <source>AIDS</source> <volume>22</volume>: <fpage>1601</fpage>–<lpage>1609</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Walson3">
        <label>9</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Walson</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>John-Stewart</surname><given-names>G</given-names></name> (<year>2007</year>) <article-title>Treatment of helminth co-infection in individuals with HIV-1: A systematic review of the literature</article-title>. <source>PLoS Negl Trop Dis</source> <volume>1</volume>: <fpage>e102</fpage> doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pntd.0000102" xlink:type="simple">10.1371/journal.pntd.0000102</ext-link>.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Levine1">
        <label>10</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Levine</surname><given-names>MM</given-names></name> (<year>2010</year>) <article-title>Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine</article-title>. <source>BMC Biology</source> <volume>8</volume>.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Walker1">
        <label>11</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Walker</surname><given-names>CLF</given-names></name>, <name name-style="western"><surname>Black</surname><given-names>RE</given-names></name> (<year>2011</year>) <article-title>Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size</article-title>. <source>BMC Public Health</source> <volume>11</volume>.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Grassly1">
        <label>12</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grassly</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Fraser</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wenger</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Deshpande</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Sutter</surname><given-names>RW</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>New strategies for the elimination of polio from India</article-title>. <source>Science</source> <volume>314</volume>: <fpage>1150</fpage>–<lpage>1153</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Labeaud1">
        <label>13</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Labeaud</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Malhotra</surname><given-names>I</given-names></name>, <name name-style="western"><surname>King</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>King</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>King</surname><given-names>CH</given-names></name> (<year>2009</year>) <article-title>Do antenatal parasite infections devalue childhood vaccination</article-title>? <source>PLoS Negl Trop Dis</source> <volume>3</volume>: <fpage>e442</fpage> doi:10.1371/journal.pntd.0000442.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Elias1">
        <label>14</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Elias</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Britton</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Aseffa</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Engers</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Akuffo</surname><given-names>H</given-names></name> (<year>2008</year>) <article-title>Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production</article-title>. <source>Vaccine</source> <volume>26</volume>: <fpage>3897</fpage>–<lpage>3902</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Noland1">
        <label>15</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Noland</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Chowdhury</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Urban</surname><given-names>JF</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Zavala</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>N</given-names></name> (<year>2010</year>) <article-title>Helminth infection impairs the immunogenicity of a Plasmodium falciparum DNA vaccine, but not irradiated sporozoites, in mice</article-title>. <source>Vaccine</source> <volume>28</volume>: <fpage>2917</fpage>–<lpage>2923</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Dadara1">
        <label>16</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Da'dara</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Harn</surname><given-names>DA</given-names></name> (<year>2010</year>) <article-title>Elimination of helminth infection restores HIV-1C vaccine-specific T cell responses independent of helminth-induced IL-10</article-title>. <source>Vaccine</source> <volume>28</volume>: <fpage>1310</fpage>–<lpage>1317</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Triki1">
        <label>17</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Triki</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Abdallah</surname><given-names>MV</given-names></name>, <name name-style="western"><surname>Ben Aissa</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Bouratbine</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ben Ali Kacem</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>1997</year>) <article-title>Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants</article-title>. <source>Vaccine</source> <volume>15</volume>: <fpage>1123</fpage>–<lpage>1129</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Cooper1">
        <label>18</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cooper</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Chico</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Losonsky</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Sandoval</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Espinel</surname><given-names>I</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR</article-title>. <source>J Infect Dis</source> <volume>182</volume>: <fpage>1199</fpage>–<lpage>1206</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Roca1">
        <label>19</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Roca</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sigauque</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Quinto</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Morais</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Berenguera</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Estimating the vaccine-preventable burden of hospitalized pneumonia among young Mozambican children</article-title>. <source>Vaccine</source> <volume>28</volume>: <fpage>4851</fpage>–<lpage>4857</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Bekker1">
        <label>20</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bekker</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Scherpbier</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Pajkrt</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Jurriaans</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zaaijer</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection</article-title>. <source>Pediatrics</source> <volume>118</volume>: <fpage>e315</fpage>–<lpage>e322</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Albonico1">
        <label>21</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Albonico</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Chitsulo</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Engels</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gabrielli</surname><given-names>AF</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Controlling soil-transmitted helminthiasis in pre-school-age children through preventive chemotherapy</article-title>. <source>PLoS Negl Trop Dis</source> <volume>2</volume>: <fpage>e126</fpage> doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pntd.0000126" xlink:type="simple">10.1371/journal.pntd.0000126</ext-link>.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-WHO1">
        <label>22</label>
        <mixed-citation publication-type="other" xlink:type="simple">WHO (2003) Report of the WHO informal consultation on the use of Praziquantel during pregnancy/lactation and albendazole/mebendazole in children under 24 months. Geneva: WHO.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-Ndirangu1">
        <label>23</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ndirangu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Barnighausen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tanser</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Tint</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Newell</surname><given-names>ML</given-names></name> (<year>2009</year>) <article-title>Levels of childhood vaccination coverage and the impact of maternal HIV status on child vaccination status in rural KwaZulu-Natal, South Africa*</article-title>. <source>Trop Med Int Health</source> <volume>14</volume>: <fpage>1383</fpage>–<lpage>1393</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0001738-DeBaets1">
        <label>24</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>De Baets</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Bulterys</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Abrams</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Kankassa</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Pazvakavambwa</surname><given-names>IE</given-names></name> (<year>2007</year>) <article-title>Care and treatment of HIV-infected children in Africa: issues and challenges at the district hospital level</article-title>. <source>Pediatr Infect Dis J</source> <volume>26</volume>: <fpage>163</fpage>–<lpage>173</lpage>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>